Meeker David P
Insider CIK 1385155 · MYOK Director · TRVI Director, 10% owner · RYTM President and CEO, Director · KARD Director · SVNT Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise deriv | 2026-09-14 | 2026-09-14 | 50,000 | — | $0 | 15,431 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise | 2026-09-14 | 2026-09-14 | 50,000 | $6.05 | $302.5K | 289,258 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2026-09-14 | 2026-09-14 | 1,817 | $104.55 | $190.0K | 241,558 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2026-09-14 | 2026-09-14 | 8,698 | $103.43 | $899.6K | 243,375 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2026-09-14 | 2026-09-14 | 30,746 | $102.35 | $3.15M | 252,073 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2026-09-14 | 2026-09-14 | 6,439 | $101.75 | $655.2K | 282,819 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2026-09-14 | 2026-09-14 | 2,300 | $105.19 | $241.9K | 239,258 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise deriv | 2026-09-14 | 2026-09-14 | 50,000 | — | $0 | 15,431 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2026-09-14 | 2026-09-14 | 2,300 | $105.19 | $241.9K | 239,258 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2026-09-14 | 2026-09-14 | 1,817 | $104.55 | $190.0K | 241,558 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2026-09-14 | 2026-09-14 | 8,698 | $103.43 | $899.6K | 243,375 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2026-09-14 | 2026-09-14 | 30,746 | $102.35 | $3.15M | 252,073 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2026-09-14 | 2026-09-14 | 6,439 | $101.75 | $655.1K | 282,819 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise | 2026-09-14 | 2026-09-14 | 50,000 | $6.05 | $302.5K | 289,258 | SEC↗ |
| KARD Kardigan, Inc. | A Award | 2026-06-17 | 2026-06-22 | 20,706 | — | $0 | 20,706 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | A Award deriv | 2026-06-03 | 2026-06-04 | 35,000 | — | $0 | 35,000 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | A Award deriv | 2026-02-11 | 2026-02-13 | 107,850 | — | $0 | 107,850 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | A Award deriv | 2026-02-11 | 2026-02-13 | 71,900 | — | $0 | 71,900 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise deriv | 2026-02-01 | 2026-02-03 | 14,125 | — | $0 | 14,125 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise deriv | 2026-02-01 | 2026-02-03 | 33,338 | — | $0 | 100,012 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise deriv | 2026-02-01 | 2026-02-03 | 21,250 | — | $0 | 42,500 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise | 2026-02-01 | 2026-02-03 | 68,713 | — | $0 | 270,538 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | F Tax w/h | 2026-02-01 | 2026-02-03 | 31,522 | $108.99 | $3.44M | 239,016 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | A Award deriv | 2025-06-11 | 2025-06-13 | 45,000 | — | $0 | 45,000 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise deriv | 2025-06-03 | 2025-06-05 | 43,620 | — | $0 | 0 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2025-06-03 | 2025-06-05 | 274 | $65.60 | $18.0K | 201,825 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2025-06-03 | 2025-06-05 | 43,346 | $65.04 | $2.82M | 202,099 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise | 2025-06-03 | 2025-06-05 | 43,620 | $4.59 | $200.2K | 245,445 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2025-02-19 | 2025-02-19 | 9,896 | $57.22 | $566.2K | 201,281 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise deriv | 2025-02-16 | 2025-02-19 | 21,250 | — | $0 | 63,750 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise | 2025-02-16 | 2025-02-19 | 21,250 | — | $0 | 211,177 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | A Award deriv | 2025-02-14 | 2025-02-19 | 200,000 | — | $0 | 200,000 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | A Award deriv | 2025-02-14 | 2025-02-19 | 133,350 | — | $0 | 133,350 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2025-02-04 | 2025-02-04 | 4,278 | $59.43 | $254.2K | 189,927 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise deriv | 2025-02-01 | 2025-02-04 | 14,125 | — | $0 | 28,250 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise | 2025-02-01 | 2025-02-04 | 14,125 | — | $0 | 194,205 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | M Exercise deriv | 2024-08-27 | 2024-08-29 | 4,555 | — | $0 | 0 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | S Sale | 2024-08-27 | 2024-08-29 | 4,555 | $2.93 | $13.3K | 352,489 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | M Exercise | 2024-08-27 | 2024-08-29 | 4,555 | $1.43 | $6.5K | 357,044 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | A Award deriv | 2024-06-13 | 2024-06-14 | 30,000 | — | $0 | 30,000 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2024-03-19 | 2024-03-19 | 45,494 | $39.22 | $1.78M | 174,605 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | A Award deriv | 2024-02-16 | 2024-02-21 | 85,000 | — | $0 | 85,000 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | A Award deriv | 2024-02-16 | 2024-02-21 | 259,000 | — | $0 | 259,000 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | A Award | 2024-02-16 | 2024-02-21 | 99,000 | — | $0 | 220,099 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise deriv | 2024-02-01 | 2024-02-05 | 14,125 | — | $0 | 42,375 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2024-02-01 | 2024-02-05 | 4,361 | $45.06 | $196.5K | 121,099 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise | 2024-02-01 | 2024-02-05 | 14,125 | — | $0 | 125,460 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | A Award deriv | 2023-06-28 | 2023-06-30 | 30,000 | — | $0 | 30,000 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | A Award deriv | 2023-02-01 | 2023-02-03 | 229,600 | — | $0 | 229,600 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | A Award deriv | 2023-02-01 | 2023-02-03 | 56,500 | — | $0 | 56,500 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | A Award deriv | 2022-06-23 | 2022-07-01 | 20,000 | — | $0 | 20,000 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | A Award deriv | 2022-06-23 | 2022-06-23 | 20,000 | — | $0 | 20,000 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | A Award deriv | 2022-02-09 | 2022-02-11 | 510,000 | — | $0 | 510,000 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | A Award deriv | 2021-06-16 | 2021-06-17 | 20,000 | — | $0 | 20,000 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | P Buy | 2021-03-30 | 2021-03-31 | 10,000 | $20.17 | $201.7K | 111,335 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | A Award deriv | 2021-02-11 | 2021-02-16 | 220,000 | — | $0 | 220,000 | SEC↗ |
| MYOK MyoKardia, Inc. | D To issuer deriv | 2020-11-17 | 2020-11-19 | 11,000 | — | $0 | 0 | SEC↗ |
| MYOK MyoKardia, Inc. | D To issuer deriv | 2020-11-17 | 2020-11-19 | 6,600 | — | $0 | 0 | SEC↗ |
| MYOK MyoKardia, Inc. | D To issuer deriv | 2020-11-17 | 2020-11-19 | 3,000 | — | $0 | 0 | SEC↗ |
| MYOK MyoKardia, Inc. | D To issuer deriv | 2020-11-17 | 2020-11-19 | 11,000 | — | $0 | 0 | SEC↗ |
| MYOK MyoKardia, Inc. | D To issuer deriv | 2020-11-17 | 2020-11-19 | 22,000 | — | $0 | 0 | SEC↗ |
| MYOK MyoKardia, Inc. | U Tender | 2020-11-17 | 2020-11-19 | 4,100 | — | $0 | 0 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | A Award deriv | 2020-07-20 | 2020-07-21 | 900,000 | — | $0 | 900,000 | SEC↗ |
| MYOK MyoKardia, Inc. | A Award deriv | 2020-06-18 | 2020-06-22 | 3,000 | — | $0 | 3,000 | SEC↗ |
| MYOK MyoKardia, Inc. | A Award deriv | 2020-06-18 | 2020-06-22 | 1,800 | — | $0 | 1,800 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | A Award deriv | 2020-06-17 | 2020-06-18 | 18,500 | — | $0 | 18,500 | SEC↗ |
| MYOK MyoKardia, Inc. | M Exercise deriv | 2020-06-13 | 2020-06-16 | 2,300 | — | $0 | 0 | SEC↗ |
| MYOK MyoKardia, Inc. | M Exercise deriv | 2020-06-13 | 2020-06-23 | 2,300 | — | $0 | 0 | SEC↗ |
| MYOK MyoKardia, Inc. | M Exercise | 2020-06-13 | 2020-06-16 | 2,300 | — | $0 | 2,300 | SEC↗ |
| MYOK MyoKardia, Inc. | M Exercise | 2020-06-13 | 2020-06-23 | 2,300 | — | $0 | 2,300 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | A Award deriv | 2020-06-11 | 2020-06-15 | 14,210 | — | $0 | 14,210 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | A Award deriv | 2019-06-19 | 2019-06-21 | 15,000 | — | $0 | 15,000 | SEC↗ |
| MYOK MyoKardia Inc | A Award deriv | 2019-06-13 | 2019-06-17 | 6,600 | — | $0 | 6,600 | SEC↗ |
| MYOK MyoKardia Inc | A Award deriv | 2019-06-13 | 2019-06-17 | 2,300 | — | $0 | 2,300 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | C Conversion deriv | 2019-05-09 | 2019-05-13 | 192,000 | — | $0 | 0 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | C Conversion deriv | 2019-05-09 | 2019-05-13 | 869,565 | — | $0 | 0 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | C Conversion deriv | 2019-05-09 | 2019-05-13 | 478,951 | — | $0 | 0 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | C Conversion deriv | 2019-05-09 | 2019-05-13 | 95,712 | — | $0 | 0 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | C Conversion deriv | 2019-05-09 | 2019-05-13 | 924,880 | — | $0 | 0 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | C Conversion | 2019-05-09 | 2019-05-13 | 27,432 | — | $0 | 327,968 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | C Conversion | 2019-05-09 | 2019-05-13 | 300,536 | — | $0 | 300,536 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | P Buy | 2019-05-09 | 2019-05-13 | 11,250 | $10.00 | $112.5K | 352,489 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | C Conversion | 2019-05-09 | 2019-05-13 | 13,271 | — | $0 | 341,239 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | A Award deriv | 2019-05-07 | 2019-05-08 | 23,684 | — | $0 | 23,684 | SEC↗ |
| MYOK MyoKardia Inc | A Award deriv | 2018-06-12 | 2018-06-14 | 11,000 | — | $0 | 11,000 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | A Award deriv | 2018-06-06 | 2018-06-08 | 10,000 | — | $0 | 10,000 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | C Conversion deriv | 2017-10-10 | 2017-10-10 | 54,525 | — | $0 | 0 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | C Conversion | 2017-10-10 | 2017-10-10 | 54,525 | — | $0 | 76,335 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | P Buy | 2017-10-10 | 2017-10-10 | 25,000 | $17.00 | $425.0K | 101,335 | SEC↗ |
| MYOK MyoKardia Inc | A Award deriv | 2017-06-14 | 2017-06-16 | 11,000 | — | $0 | 11,000 | SEC↗ |
| MYOK MyoKardia Inc | A Award deriv | 2017-04-17 | 2017-04-19 | 22,000 | — | $0 | 22,000 | SEC↗ |
| SVNT SAVIENT PHARMACEUTICALS IN | A Award deriv | 2013-01-07 | 2013-01-17 | 16,415 | $1.17 | $19.2K | 16,415 | SEC↗ |
| SVNT SAVIENT PHARMACEUTICALS IN | A Award | 2013-01-07 | 2013-01-17 | 12,644 | $1.17 | $14.8K | 12,644 | SEC↗ |